Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy

This study was sponsored by French National Agency for HIV/AIDS and Viral Hepatitis Research (ANRS) (Paris, France) and was funded by ANRS and the Brazilian government.

Detalles Bibliográficos
Autores: Taburet, Anne-Marie, Sauvageon, Hélène, Grinsztejn, Beatriz, Assuied, Alex, Veloso, Valdiléa G., Pilotto, José Henrique, Castro, Nathalie de, Grondin, Carine, Fagard, Catherine, Molina, Jean-Michel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:Brasil
Institución:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Repositório Institucional da FIOCRUZ (ARCA)
Idioma:inglés
OAI Identifier:oai:arca.fiocruz.br:icict/14016
Acceso en línea:https://arca.fiocruz.br/handle/icict/14016
Access Level:acceso abierto
Palabra clave:HIV
Tuberculose
Farmacocinética
Raltegravir
Rifampina
Descripción
Sumario:This study was sponsored by French National Agency for HIV/AIDS and Viral Hepatitis Research (ANRS) (Paris, France) and was funded by ANRS and the Brazilian government.

Similares en LA Referencia